Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study99

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study12

Views

Views
December 20251
January 20261
February 20260
March 20261
April 20261
May 20267
June 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
United Kingdom2
Spain1
South Korea1
Netherlands1
Paraguay1
 

Top cities views

Views
Los Angeles2
Amsterdam1
Bolingbrook1
Ciudad del Este1
Madrid1
Seoul1
Vacaville1